These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
1129 related articles for article (PubMed ID: 15718497)
21. Aldosterone up-regulates 12- and 15-lipoxygenase expression and LDL oxidation in human vascular smooth muscle cells. Limor R; Kaplan M; Sharon O; Knoll E; Naidich M; Weisinger G; Keidar S; Stern N J Cell Biochem; 2009 Dec; 108(5):1203-10. PubMed ID: 19795383 [TBL] [Abstract][Full Text] [Related]
22. Angiotensin II induces matrix metalloproteinase-9 expression via a nuclear factor-kappaB-dependent pathway in vascular smooth muscle cells. Guo RW; Yang LX; Wang H; Liu B; Wang L Regul Pept; 2008 Apr; 147(1-3):37-44. PubMed ID: 18252266 [TBL] [Abstract][Full Text] [Related]
23. Cross-talk between aldosterone and angiotensin II in vascular smooth muscle cell senescence. Min LJ; Mogi M; Iwanami J; Li JM; Sakata A; Fujita T; Tsukuda K; Iwai M; Horiuchi M Cardiovasc Res; 2007 Dec; 76(3):506-16. PubMed ID: 17706954 [TBL] [Abstract][Full Text] [Related]
24. SSeCKS gene expression in vascular smooth muscle cells: regulation by angiotensin II and a potential role in the regulation of PAI-1 gene expression. Coats SR; Covington JW; Su M; Pabón-Peña LM; Eren M; Hao Q; Vaughan DE J Mol Cell Cardiol; 2000 Dec; 32(12):2207-19. PubMed ID: 11112996 [TBL] [Abstract][Full Text] [Related]
26. Aldosterone causes vasoconstriction in coronary arterioles of rats via angiotensin II type-1 receptor: influence of hypertension. Kushibiki M; Yamada M; Oikawa K; Tomita H; Osanai T; Okumura K Eur J Pharmacol; 2007 Oct; 572(2-3):182-8. PubMed ID: 17644087 [TBL] [Abstract][Full Text] [Related]
27. Aldosterone administration to mice stimulates macrophage NADPH oxidase and increases atherosclerosis development: a possible role for angiotensin-converting enzyme and the receptors for angiotensin II and aldosterone. Keidar S; Kaplan M; Pavlotzky E; Coleman R; Hayek T; Hamoud S; Aviram M Circulation; 2004 May; 109(18):2213-20. PubMed ID: 15123520 [TBL] [Abstract][Full Text] [Related]
28. Expression and function of the human mineralocorticoid receptor: lessons from transgenic mouse models. Le Menuet D; Viengchareun S; Muffat-Joly M; Zennaro MC; Lombès M Mol Cell Endocrinol; 2004 Mar; 217(1-2):127-36. PubMed ID: 15134811 [TBL] [Abstract][Full Text] [Related]
30. Angiotensin II modulates frizzled-2 receptor expression in rat vascular smooth muscle cells. Castoldi G; Redaelli S; van de Greef WM; di Gioia CR; Busca G; Sperti G; Stella A Clin Sci (Lond); 2005 Jun; 108(6):523-30. PubMed ID: 15667337 [TBL] [Abstract][Full Text] [Related]
31. Aldosterone and angiotensin II synergistically stimulate migration in vascular smooth muscle cells through c-Src-regulated redox-sensitive RhoA pathways. Montezano AC; Callera GE; Yogi A; He Y; Tostes RC; He G; Schiffrin EL; Touyz RM Arterioscler Thromb Vasc Biol; 2008 Aug; 28(8):1511-8. PubMed ID: 18467645 [TBL] [Abstract][Full Text] [Related]
32. Angiotensin IV activates the nuclear transcription factor-kappaB and related proinflammatory genes in vascular smooth muscle cells. Esteban V; Ruperez M; Sánchez-López E; Rodríguez-Vita J; Lorenzo O; Demaegdt H; Vanderheyden P; Egido J; Ruiz-Ortega M Circ Res; 2005 May; 96(9):965-73. PubMed ID: 15831814 [TBL] [Abstract][Full Text] [Related]
33. Gene expression profiles of vascular smooth muscle show differential expression of mitogen-activated protein kinase pathways during captopril therapy of heart failure. Chen FC; Brozovich FV J Vasc Res; 2008; 45(5):445-54. PubMed ID: 18418003 [TBL] [Abstract][Full Text] [Related]
34. Mineralocorticoid receptor and 11beta-hydroxysteroid dehydrogenase type II expression in renal cell neoplasms: a tissue microarray and quantitative RT-PCR study. Yakirevich E; Morris DJ; Tavares R; Meitner PA; Lechpammer M; Noble L; de Rodriguez AF; Gomez-Sanchez CE; Wang LJ; Sabo E; Delellis RA; Resnick MB Am J Surg Pathol; 2008 Jun; 32(6):874-83. PubMed ID: 18408592 [TBL] [Abstract][Full Text] [Related]
35. Angiotensin II induces the expression of tissue factor and its mechanism in human monocytes. He M; He X; Xie Q; Chen F; He S Thromb Res; 2006; 117(5):579-90. PubMed ID: 15953627 [TBL] [Abstract][Full Text] [Related]
36. RhoA mediates angiotensin II-induced phospho-Ser536 nuclear factor kappaB/RelA subunit exchange on the interleukin-6 promoter in VSMCs. Cui R; Tieu B; Recinos A; Tilton RG; Brasier AR Circ Res; 2006 Sep; 99(7):723-30. PubMed ID: 16960103 [TBL] [Abstract][Full Text] [Related]
37. Aldosterone-induced coronary dysfunction in transgenic mice involves the calcium-activated potassium (BKCa) channels of vascular smooth muscle cells. Ambroisine ML; Favre J; Oliviero P; Rodriguez C; Gao J; Thuillez C; Samuel JL; Richard V; Delcayre C Circulation; 2007 Nov; 116(21):2435-43. PubMed ID: 17984374 [TBL] [Abstract][Full Text] [Related]
38. Delineating the receptor mechanisms underlying the rapid vascular contractile effects of aldosterone and estradiol. Gros R; Ding Q; Davis M; Shaikh R; Liu B; Chorazyczewski J; Pickering JG; Feldman RD Can J Physiol Pharmacol; 2011 Sep; 89(9):655-63. PubMed ID: 21854125 [TBL] [Abstract][Full Text] [Related]
39. Stimulation of testosterone production in rat Leydig cells by aldosterone is mineralocorticoid receptor mediated. Ge RS; Dong Q; Sottas CM; Latif SA; Morris DJ; Hardy MP Mol Cell Endocrinol; 2005 Nov; 243(1-2):35-42. PubMed ID: 16188378 [TBL] [Abstract][Full Text] [Related]
40. Novel transcripts of Nox1 are regulated by alternative promoters and expressed under phenotypic modulation of vascular smooth muscle cells. Arakawa N; Katsuyama M; Matsuno K; Urao N; Tabuchi Y; Okigaki M; Matsubara H; Yabe-Nishimura C Biochem J; 2006 Sep; 398(2):303-10. PubMed ID: 16724959 [TBL] [Abstract][Full Text] [Related] [Previous] [Next] [New Search]